Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AGENT FOR TREATMENT OR PREVENTION OF HTLV-1-ASSOCIATED MYELOPATHY (HAM), AND HAM TREATMENT METHOD
Document Type and Number:
WIPO Patent Application WO/2020/017629
Kind Code:
A1
Abstract:
The present invention provides: an agent for the treatment or prevention of HTLV-1-associated myelopathy (HAM), the agent containing an RGMa inhibitor; and a HAM treatment method including the administration of a pharmacologically effective amount of an RGMa inhibitor to an HTLV-1-associated myelopathy (HAM) patient in need of the agent.

Inventors:
UCHIMARU KAORU (JP)
YAMAGISHI MAKOTO (JP)
ISHIZAKI IZUMI (JP)
YAMANO YOSHIHISA (JP)
Application Number:
PCT/JP2019/028431
Publication Date:
January 23, 2020
Filing Date:
July 19, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TOKYO (JP)
UNIV SCHOOL ST MARIANNA MEDICINE (JP)
International Classes:
A61K45/00; A61K39/395; A61P25/00; A61P31/12; A61P43/00
Domestic Patent References:
WO2017210278A12017-12-07
WO2016175236A12016-11-03
WO2005087268A12005-09-22
WO2014007303A12014-01-09
WO2011071059A12011-06-16
WO2016175236A12016-11-03
Foreign References:
JP2006516594A2006-07-06
JP2013119531A2013-06-17
JP2014138599A2014-07-31
JP2016175897A2016-10-06
JP2017526930W
JP2010100578A2010-05-06
JP2015508061W
Other References:
N ENGL J MED, vol. 378, 2018, pages 529 - 538
YAMASHITA, T.MUELLER, B.K.HATA, K.: "Neogenin and repulsive guidance molecule signaling in the central nervous system", CURR. OPIN. NEUROBIOL., vol. 17, 2007, pages 29 - 34, XP005931698, DOI: 10.1016/j.conb.2006.12.001
KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1987, US DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIH
See also references of EP 3824907A4
Attorney, Agent or Firm:
INABA, Yoshiyuki et al. (JP)
Download PDF: